Medicare Enrolled
Catherine Dillane
Cardiovascular Disease · King Of Prussia, PA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dillane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dillane?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dillane
Catherine Dillane is a cardiovascular disease specialist in King Of Prussia, PA, with 12 years of NPI registration. Based on federal Medicare data, Dillane performed 2,259 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dillane received a total of $1,676 from 22 pharmaceutical and/or device companies across 117 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dillane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 42% volume in PA
$1,676 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,259
Medicare services
Top 42% in PA for cardiovascular disease
Not available
Unique patients (not deduplicated)
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
723 | $99 | $281 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
388 | $11 | $32 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
192 | $128 | $359 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
123 | $102 | $290 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
123 | $66 | $152 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
116 | $43 | $123 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
81 | $127 | $362 |
| Intensive cardiac rehabilitation without exercise An intensive cardiac rehabilitation session that does not include exercise. The procedure may include continuous ECG monitoring during the session. |
81 | $101 | $256 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
67 | $50 | $160 |
| Outpatient cardiac rehabilitation with ECG monitoring Supervised heart rehabilitation program including electrocardiogram monitoring and professional healthcare services. |
57 | $22 | $58 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
43 | $101 | $160 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
40 | $378 | $1,047 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
39 | $11 | $34 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
37 | $21 | $58 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $147 | $395 |
| Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | 27 | $98 | $256 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
21 | $20 | $54 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $145 | $422 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $72 | $200 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $76 | $199 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
12 | $99 | $218 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
11 | $20 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
8.5% high complexity
12.7% medium
78.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,676
Total received (2018-2024)
Avg $335/year across 5 years
Bottom 46% in PA for cardiovascular disease
22
Companies
117
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$163
2023
$367
2022
$579
2021
$548
2018
$18
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$48
Esperion Therapeutics, Inc.
$42
Boston Scientific Corporation
$23
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$19
Kiniksa Pharmaceuticals International, plc
$16
Philips North America LLC
$15
Top 3 companies account for 69.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$530
Boston Scientific Corporation
$284
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$172
Impulse Dynamics (USA) Inc.
$83
Esperion Therapeutics, Inc.
$70
Janssen Pharmaceuticals, Inc
$68
Daiichi Sankyo Inc.
$63
AstraZeneca Pharmaceuticals LP
$51
Kiniksa Pharmaceuticals, Ltd.
$47
Preventice Services, LLC
$47
Philips Electronics North America Corporation
$46
SANOFI-AVENTIS U.S. LLC
$42
PFIZER INC.
$27
E.R. Squibb & Sons, L.L.C.
$24
Medtronic Vascular, Inc.
$18
Kiniksa Pharmaceuticals International, plc
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Merck Sharp & Dohme LLC
$15
Amgen Inc.
$15
Philips North America LLC
$15
Kowa Pharmaceuticals America, Inc.
$15
Merck Sharp & Dohme Corporation
$13
Top 3 companies account for 58.8% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Extended Holter · Arcalyst · Azure · BG Mini Plus · BRILINTA · CAMZYOS · ELIQUIS · ENTRESTO · FARXIGA · General - Therapies · INJECTAFER · JARDIANCE · LEQVIO · LifeVest · Livalo · MULTAQ · NEXLETOL · Optimizer · Repatha · VERQUVO · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
672
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
VALLEY FORGE MEDICAL CENTER
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dillane is a cardiac & electrophysiology specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dillane experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dillane performed 723 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dillane receive payments from pharmaceutical companies?
Yes. Dillane received a total of $1,676 from 22 companies across 117 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dillane's costs compare to other cardiologists in King Of Prussia?
Dillane's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dillane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in King Of Prussia
Browse cardiologists in King Of Prussia ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology